Abstract
Light-chain deposition disease (LCDD) is a systemic disease characterized by monotypic light-chain (LC) deposits. Although various organs may be affected, it is usually heralded by renal involvement. Diagnosis is made on immunohistologic findings: deposits are reactive with one anti-light-chain antiserum (kappa or lambda) and lack amyloid characteristics. LCDD is always associated with B-cell dyscrasias, but in one third of reported cases the lymphoplasmacytic proliferation does not fit the usual criteria for malignancy. In this article we review the prominent pathological and clinical features that are currently important to consider in the clinical care of patients with LCDD.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Ivanyi B: Frequency of light chain deposition nephropathy relative to renal amyloidosis and Bence-Jones cast nephropathy in a necropsy study of patients with myeloma. Arch Pathol Lab Med, 114: 986–987, 1990.
Fang LST: Light-chain nephropathy. Kidney Int, 27: 582–592, 1985.
Kyle RA: Monoclonal gammopathies and the kidney. Ann Rev Med, 40: 53–60, 1989.
Sturgill BC, Tucker FL, Bolton WK: Immunoglobulin light chain nephropathies. Pathol Annu, 22: 133–150, 1987.
Hill GS: Dysproteinemias, amyloidosis and immunotactoid glomerulopathy. In: “Pathology of the kidney” (Ed RH Hepstinstall), Vol. 2, Little Brown, Boston, 1991, pp 1631–1713.
Noël LH, Droz D, Ganeval D, Grünfeld JP: Renal granular monoclonal light chain deposits: morphological aspects in 11 cases. Gin Nephrol, 21: 263–269, 1984.
Solomon A, Weiss DT, Kattine AA: Nephrotoxic potential of Bence-Jones proteins. N Engl J Med, 324: 1845–1851, 1991.
Sanders PW, Herrera GA, Kirk KA, Old CW, Galla JH: Spectrum of glomerular and tubulointerstitial renal lesions associated with monoclonal immunoglobulin light chain deposition. Lab Invest, 64: 527–537, 1991.
Ganeval D, Noel LH, Preud’phomme JL, Droz D, Grünfeld JP: Light-chain deposition disease: its relation with Al-type amyloidosis. Kidney Int, 26:1–9, 1984.
Sinniah R, Cohen AM: Glomerular capillary aneurysms in light-chain nephropathy. Am J Pathol, 118:298–305, 1985.
Bangertner AR, Murphy WM: Kappa light chain nephropathy. Virchows Arch A, 410: 531–539, 1987.
Alpers CE: Immunotactoid glomerulopathy: an entity distinct from fibrillary glomerulonephritis. Am J Kidney Dis, 19: 185–191, 1992.
Gallo G, Picken M, Buxbaum J, Frangione B: The spectrum of monoclonal immunoglobulin deposition disease associated with immunocytic dyscrasias. Semin Hematol, 26: 234–245, 1989.
Randall RE, Williamson WC, Mullinax F, Tung MY, Still WJS: Manifestations of systemic light chain deposition. Am J Med, 60: 293–299, 1980.
Buxbaum JN, Chuba JV, Hellman GC, Solomon AL, Gallo GR: Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Ann Int Med, 112: 455–464, 1990.
Droz D, Noel LH, Carnot F, Degos F, Ganeval D, Grünfeld JP: Liver involvement in nonamyloid light chain deposits disease. Lab Invest, 50: 683–689, 1984.
Voinchet O, Degott C, Scoazec JY, Feldmann G, Benhamou JP: Peliosis hepatis, nodular regenerative hyperplasia of the liver and light-chain deposition in a patient with Waldenström’s macroglobulinemia. Gastroenterology, 95: 482–486, 1988.
Dalakas MC, Engel WK: Polyneuropathy with monoclonal gammopathies: studies of 11 patients. Ann Neurol, 10: 45–52, 1981.
Kijner CM, Yousem SA: Systemic light chain deposition disease presenting as multiple pulmonary nodules. Am J Surg Pathol, 12: 405–413, 1988.
Tubbs RR, Gephardt GN, McNahon JT, Hall PM, Valenzuela R, Vidt DG: Light chain nephropathy. Am J Med, 71: 263–269, 1981.
Confalioneri R, Barbiano di Belgiojoso G, Banfi G, Ferrario F, Bertani T, Pozzi C, Casanova S, Lupo A, de Ferrari G, Minetti L: Light chain nephropathy: histological and clinical aspects in 15 cases. Nephrol Dial Transplant, 2: 150–156, 1988.
Nakamato Y, Imai H, Hamanaka S, Yoshida K, Akihama T, Miura AB: IgM monoclonal gammopathy accompanied by nodular glomerulosclerosis, urine-concentrating defect and hyporeninemic hypoaldosteronism. Am J Nephrol, 5: 53–58, 1985.
Peng SK, French WJ, Cohen AH, Fausel RE: Light chain cardiomyopathy associated with small-vessel disease. Arch Pathol Lab Med, 112: 844–846, 1988.
Bedossa P, Fabre M, Paraf F, Martin E, Lemaigre G: Light chain deposition disease with liver dysfunction. Human Pathol, 19: 1008–1014, 1988.
Faa G, Van Eyken P, De Vos R, Fevery J, Van Damme B, De Groote J, Desmet VJ: Light chain deposition disease of the liver associated with AL-type amyloidosis and severe cholestasis. J Hepatol, 12: 75–82, 1991.
Maury CPJ, Teppo AM: Massive cutaneous hyalinosis. Am J Clin Pathol, 82: 543–551, 1984.
Rahman A, Mossey RT, Susin M, Budman D, Mailloux LU: Kappa-chain nephropathy associated with plasma cell leukemia. Arch Int Med, 144: 1689–1690, 1984.
Preud’homme JL: Immunoglobulin synthesis in plasma cell dyscrasias with renal lesions. In: “The kidney in plasma cell dyscrasias” (Eds L Minetti, G D’Amico, C Ponticelli), Kluwer Academic Publishers, Dordrecht, The Netherlands, 1988, pp 31–43.
Matsuzaki H, Yoshida M, Akahoshi Y, Kuwahara K, Satout T, Takatsuki K: Pseudo-nonsecretory multiple myeloma with light chain deposition disease. Acta Haematol, 85: 164–168, 1991.
Heilman RL, Holley K, Offord K, Velosa J, Kyle R: Apparent renal response to melphalan and prednisone (MP) in light chain deposition disease. Kidney Int, 35: 209A, 1988 (Abstract).
Gipstein RM, Cohen AH, Adams DA, Adams T, Grabie MT: Kappa light chain nephropathy without evidence of myeloma cells. Response to chemotherapy with cessation of maintenance hemodialysis. Am J Nephrol, 2: 276–281, 1982.
Alpers CE, Marchioro TL, Johnson RJ: Monoclonal immunoglobulin deposition disease in a renal allograft: probable recurrent disease in a patient without myeloma. Am J Kidney Dis, 13: 418–423, 1989.
Gerlag PGG, Koene RAP, Berden JHM: Renal transplantation in light chain nephropathy: case report and review of the literature. Clin Nephrol, 25: 101–104, 1986.
Picken MM, Frangione B, Barlogie B, Luna M, Gallo G: Light chain deposition disease derived from the K1 light chain subgroup. Am J Pathol, 134: 749–754, 1989.
Cogne M, Preud’homme JL, Bauwens M, Touchard G, Aucouturier P: Structure of a monoclonal kappa chain of the VKIV subgroup in the kidney and plasma cells in light chain deposition disease. J Clin Invest, 87: 2188–2190, 1991.
Khamlichi AA, Aucouturier P, Silvain C, Bauwens M, Touchard G, Preud’homme JL, Nau F, Cogne M: Primary structure of a monoclonal k chain in myeloma with light chain deposition disease. Clin Exp Immunol, 87: 122–126, 1992.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag London Limited
About this chapter
Cite this chapter
Chauveau, D., Ganeval, D. (1992). Light-Chain Deposition Disease: Diagnosis, Prognosis and Therapy. In: Andreucci, V.E., Fine, L.G. (eds) International Yearbook of Nephrology 1993. Springer, London. https://doi.org/10.1007/978-1-4471-1948-7_3
Download citation
DOI: https://doi.org/10.1007/978-1-4471-1948-7_3
Publisher Name: Springer, London
Print ISBN: 978-1-4471-1950-0
Online ISBN: 978-1-4471-1948-7
eBook Packages: Springer Book Archive